ST Elevatation Myocardial Infarction (STEMI) Clinical Trial
— Prok-IdmOfficial title:
Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction
| NCT number | NCT02021487 |
| Other study ID # | 5515 |
| Secondary ID | |
| Status | Terminated |
| Phase | |
| First received | |
| Last updated | |
| Start date | November 2013 |
| Est. completion date | February 2019 |
| Verified date | August 2019 |
| Source | University Hospital, Strasbourg, France |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The study aims to investigate the presence of a substance in the blood called prokinecitine, which is released by the heart when a heart attack occurs. Several venous blood samples at the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the concentration of this substance in the blood. The usefulness of this new blood marker is going to be determsined to seek if it would be of help to better diagnose or estimate the gravity of heart infarction after a heart attack.
| Status | Terminated |
| Enrollment | 172 |
| Est. completion date | February 2019 |
| Est. primary completion date | February 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patients with acute St elevation myocardial infarction of less than 6 hours - Age>18 y/o Exclusion Criteria: - Previous myocardial infarction - LBB, RBB - Renal Insuffiency MDRD<30 mL/min - Patient with Pace-Maker or ICD. |
| Country | Name | City | State |
|---|---|---|---|
| France | University Hospital | Strasbourg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Strasbourg, France |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Infarct size by MRI necrotic myocardial mass | Infarct size by MRI necrotic myocardial mass | 7 days |